Exploring how pancreatic cancer interacts with the immune system and responds to treatments.
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping
This study is looking at how the immune system interacts with pancreatic cancer to find better ways to treat it, and if you're a patient, you might have the chance to help by joining trials testing new treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-11052505 on NIH RePORTER |
What this research studies
This research investigates the immune microenvironment of pancreatic ductal adenocarcinoma (PDAC) and how it affects treatment responses. By using advanced imaging techniques, the study aims to visualize and track immune cells within the tumor, particularly focusing on immunosuppressive myeloid cells. The researchers will also explore innovative methods to enhance the effectiveness of immunotherapy in treating PDAC, which is known to be resistant to current treatments. Patients may have the opportunity to contribute to this groundbreaking work by participating in trials that assess new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are seeking new treatment options.
Not a fit: Patients with other types of cancer or those who do not have pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients with pancreatic cancer, potentially enhancing their survival rates.
How similar studies have performed: Previous research has shown promise in using immunotherapy for other cancers, but this approach in pancreatic cancer is still largely untested.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Yan, Jun — University of Louisville
- Study coordinator: Yan, Jun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.